Winmill & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Winmill & Co's DGX Position: Q4 2016 in Review
Winmill & Co sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 28,000 shares — an estimated $2.37M sold.
Winmill & Co first reported a position in DGX in Q1 2014 and held it in 11 quarters. The position peaked at $2.37M in Q3 2016. 599 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- Winmill & Co reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
- Winmill & Co sold 28,000 Quest Diagnostics shares in Q4 2016, an estimated $2.37M.
- Winmill & Co first reported a position in Quest Diagnostics in Q1 2014 and held it in 11 quarters.
- Winmill & Co's Quest Diagnostics position peaked at $2.37M in Q3 2016.
- 599 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on Winmill & Co's 13F filing for Q4 2016, filed 7 Feb 2017.